SEARCH

SEARCH BY CITATION

References

  • 1
    Darbari DS,Kple-Faget P,Kwagyan J, et al. Circumstances of death in adult sickle cell disease patients. Am J Hematol 2006; 81: 858863.
  • 2
    Sonakul D,Pacharee P,Thakerngpol K. Pathologic findings in 76 autopsy cases of thalassemia. Birth Defects Orig Artic Ser 1988; 23: 157176.
  • 3
    Olivieri NF. Progression of iron overload in sickle cell disease. Semin Hematol 2001; 38: 5762.
  • 4
    Anderson GJ. Mechanisms of iron loading and toxicity. Am J Hematol 2007; 82: 11281131.
  • 5
    Porter JB. Concepts and goals in the management of transfusional iron overload. Am J Hematol 2007; 82: 11361139.
  • 6
    Vichinsky E,Butensky E,Fung E, et al. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. Am J Hematol 2005; 80: 7074.
  • 7
    Walter PB,Fung EB,Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006; 135: 254263.
  • 8
    Fung EB,Harmatz PR,Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006; 135: 574582.
  • 9
    Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 2006; 46: 554557.
  • 10
    Sohn YS,Breuer W,Munnich A, et al. Redistribution of accumulated cell iron: A modality of chelation with therapeutic implications. Blood 2008; 111: 16901699.
  • 11
    Kattamis A,Papassotiriou I,Palaiologou D, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006; 91: 809812.
  • 12
    Kearney SL,Nemeth E,Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007; 48: 5763.
  • 13
    Mcnamara L,Macphail AP,Mandishona E, et al. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload. J Gastroenterol Hepatol 1999; 14: 126132.
  • 14
    Harmatz P,Butensky E,Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000; 96: 7679.
  • 15
    Fung EB,Harmatz PR,Milet M, et al. Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions. Transfusion 2008; 48: 19711980.
  • 16
    Schein A,Enriquez C,Coates TD, et al. Magnetic resonance detection of kidney iron deposition in sickle cell disease: A marker of chronic hemolysis. J Magn Reson Imaging 2008; 28: 698704.
  • 17
    Fung EB,Harmatz P,Milet M, et al. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload. Am J Hematol 2007; 82: 255265.
  • 18
    Wood JC,Tyszka JM,Ghugre N, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood 2004; 103: 19341936.
  • 19
    Nishina S,Hino K,Korenaga M, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008; 134: 226238.
  • 20
    Takeo M,Kobayashi Y,Fujita N, et al. Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. J Gastroenterol Hepatol 2005; 20: 562569.
  • 21
    Fujita N,Sugimoto R,Takeo M, et al. Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13: 97104.
  • 22
    Gabutti V,Borgna-Pignatti C. Clinical manifestations and therapy of transfusional haemosiderosis. Baillieres Clin Haematol 1994; 7: 919940.
  • 23
    Wood J,Aguilar M,Otto-Duessel M, et al. Influence of iron chelation therapy on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med 2008; 60: 8289.
  • 24
    Wood JC,Otto-Duessel M,Gonzalez I, et al. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Transl Res 2006; 148: 272280.
  • 25
    Butensky E,Fischer R,Hudes M, et al. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 2005; 123: 146152.
  • 26
    Deugnier YM,Loreal O,Turlin B, et al. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102: 20502059.